190 related articles for article (PubMed ID: 28190248)
1. Opposing roles of Nfkb2 gene products p100 and p52 in the regulation of breast cancer stem cells.
Yeo SK; French R; Spada F; Clarkson R
Breast Cancer Res Treat; 2017 Apr; 162(3):465-477. PubMed ID: 28190248
[TBL] [Abstract][Full Text] [Related]
2. The Transitional Endoplasmic Reticulum ATPase p97 Regulates the Alternative Nuclear Factor NF-κB Signaling via Partial Degradation of the NF-κB Subunit p100.
Zhang Z; Wang Y; Li C; Shi Z; Hao Q; Wang W; Song X; Zhao Y; Jiao S; Zhou Z
J Biol Chem; 2015 Aug; 290(32):19558-68. PubMed ID: 26112410
[TBL] [Abstract][Full Text] [Related]
3. Highly-expressed p100/p52 (NFKB2) sequesters other NF-kappa B-related proteins in the cytoplasm of human breast cancer cells.
Dejardin E; Bonizzi G; Bellahcène A; Castronovo V; Merville MP; Bours V
Oncogene; 1995 Nov; 11(9):1835-41. PubMed ID: 7478612
[TBL] [Abstract][Full Text] [Related]
4. A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses.
de Oliveira KA; Kaergel E; Heinig M; Fontaine JF; Patone G; Muro EM; Mathas S; Hummel M; Andrade-Navarro MA; Hübner N; Scheidereit C
Genome Med; 2016 Mar; 8(1):28. PubMed ID: 26988706
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of NF-kappaB signaling proteins IKKepsilon, p50/p105, p52/p100 and RelA in prostate cancers.
Seo SI; Song SY; Kang MR; Kim MS; Oh JE; Kim YR; Lee JY; Yoo NJ; Lee SH
APMIS; 2009 Aug; 117(8):623-8. PubMed ID: 19664134
[TBL] [Abstract][Full Text] [Related]
6. NF-kappaB signalling proteins p50/p105, p52/p100, RelA, and IKKepsilon are over-expressed in oesophageal squamous cell carcinomas.
Kang MR; Kim MS; Kim SS; Ahn CH; Yoo NJ; Lee SH
Pathology; 2009; 41(7):622-5. PubMed ID: 20001340
[TBL] [Abstract][Full Text] [Related]
7. Role of NF-kappaB2-p100 in regulatory T cell homeostasis and activation.
Dhar A; Chawla M; Chattopadhyay S; Oswal N; Umar D; Gupta S; Bal V; Rath S; George A; Arimbasseri GA; Basak S
Sci Rep; 2019 Sep; 9(1):13867. PubMed ID: 31554891
[TBL] [Abstract][Full Text] [Related]
8. Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype.
Guo X; Koff JL; Moffitt AB; Cinar M; Ramachandiran S; Chen Z; Switchenko JM; Mosunjac M; Neill SG; Mann KP; Bagirov M; Du Y; Natkunam Y; Khoury HJ; Rossi MR; Harris W; Flowers CR; Lossos IS; Boise LH; Dave SS; Kowalski J; Bernal-Mizrachi L
Oncogene; 2017 Jul; 36(29):4224-4232. PubMed ID: 28368397
[TBL] [Abstract][Full Text] [Related]
9. The generation of nfkb2 p52: mechanism and efficiency.
Heusch M; Lin L; Geleziunas R; Greene WC
Oncogene; 1999 Nov; 18(46):6201-8. PubMed ID: 10597218
[TBL] [Abstract][Full Text] [Related]
10. Stat3 activation of NF-{kappa}B p100 processing involves CBP/p300-mediated acetylation.
Nadiminty N; Lou W; Lee SO; Lin X; Trump DL; Gao AC
Proc Natl Acad Sci U S A; 2006 May; 103(19):7264-9. PubMed ID: 16651533
[TBL] [Abstract][Full Text] [Related]
11. Processing of the NF-kappa B2 precursor p100 to p52 is critical for RANKL-induced osteoclast differentiation.
Maruyama T; Fukushima H; Nakao K; Shin M; Yasuda H; Weih F; Doi T; Aoki K; Alles N; Ohya K; Hosokawa R; Jimi E
J Bone Miner Res; 2010 May; 25(5):1058-67. PubMed ID: 19874202
[TBL] [Abstract][Full Text] [Related]
12. A transgenic model reveals important roles for the NF-kappa B alternative pathway (p100/p52) in mammary development and links to tumorigenesis.
Connelly L; Robinson-Benion C; Chont M; Saint-Jean L; Li H; Polosukhin VV; Blackwell TS; Yull FE
J Biol Chem; 2007 Mar; 282(13):10028-10035. PubMed ID: 17261585
[TBL] [Abstract][Full Text] [Related]
13. CNK1 promotes invasion of cancer cells through NF-kappaB-dependent signaling.
Fritz RD; Radziwill G
Mol Cancer Res; 2010 Mar; 8(3):395-406. PubMed ID: 20197385
[TBL] [Abstract][Full Text] [Related]
14. ABINs inhibit EGF receptor-mediated NF-kappaB activation and growth of EGF receptor-overexpressing tumour cells.
Huang L; Verstrepen L; Heyninck K; Wullaert A; Revets H; De Baetselier P; Beyaert R
Oncogene; 2008 Oct; 27(47):6131-40. PubMed ID: 18622428
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of SDF-1 activates the NF-κB pathway to induce epithelial to mesenchymal transition and cancer stem cell-like phenotypes of breast cancer cells.
Kong L; Guo S; Liu C; Zhao Y; Feng C; Liu Y; Wang T; Li C
Int J Oncol; 2016 Mar; 48(3):1085-94. PubMed ID: 26782945
[TBL] [Abstract][Full Text] [Related]
16. Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3.
Cogswell PC; Guttridge DC; Funkhouser WK; Baldwin AS
Oncogene; 2000 Feb; 19(9):1123-31. PubMed ID: 10713699
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulatory effects of lymphoma-associated NFKB2/lyt10 protooncogenes.
Kim KE; Gu C; Thakur S; Vieira E; Lin JC; Rabson AB
Oncogene; 2000 Mar; 19(10):1334-45. PubMed ID: 10713675
[TBL] [Abstract][Full Text] [Related]
18. Nfkb2 variants reveal a p100-degradation threshold that defines autoimmune susceptibility.
Wirasinha RC; Davies AR; Srivastava M; Sheridan JM; Sng XYX; Delmonte OM; Dobbs K; Loh KL; Miosge LA; Lee CE; Chand R; Chan A; Yap JY; Keller MD; Chen K; Rossjohn J; La Gruta NL; Vinuesa CG; Reid HH; Lionakis MS; Notarangelo LD; Gray DHD; Goodnow CC; Cook MC; Daley SR
J Exp Med; 2021 Feb; 218(2):. PubMed ID: 33107914
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding.
Hu J; Colburn NH
Mol Cancer Res; 2005 Feb; 3(2):100-9. PubMed ID: 15755876
[TBL] [Abstract][Full Text] [Related]
20. Myc suppression of Nfkb2 accelerates lymphomagenesis.
Keller U; Huber J; Nilsson JA; Fallahi M; Hall MA; Peschel C; Cleveland JL
BMC Cancer; 2010 Jul; 10():348. PubMed ID: 20598117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
